Reactivation of VX-inhibited AChE by novel oximes having two oxygen atoms in the linker

Environmental Toxicology and Pharmacology

Volumn 30, Issue 1, 2010, Pages 85-87

  Kuca, Kamil ^a,b   Cabal, Jiri ^b   Jun, Daniel ^a,b   Musilek, Kamil ^b   Soukup, Ondrej ^b   Pohanka, Miroslav ^a   Pejchal, Jaroslav ^a   Oh, Kyung Ae ^c   Yang, Garp Yeol ^c   Jung, Young Sik ^c  

^a Center of Advanced Studies   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Cholinesterase; HI 6; Nerve agent; Oxime; Reactivator; VX

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; CYCLOSPORIN; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; OBIDOXIME; OXIME DERIVATIVE; OXYGEN; PRALIDOXIME; SOMAN;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN HOMOGENATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME REACTIVATION; INTOXICATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 77953362679     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.03.011     Document Type: Article

References (28)

1. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Advanced Clinical Chemistry 2004, 38:151-216.
2. Bajgar J., Fusek J., Kuca K., Bartosova L., Jun D. Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini-Reviews in Medicinal Chemistry 2007, 7:461-466.
3. Bartosova L., Kuca K., Jun D., Kunesova G. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing. International Journal of Toxicology 2005, 24:399-402.
4. Boskovic B., Kovacevic V., Jovanovic D. PAM-2 Cl, HI-6, and HGG-12 in soman nad tabuin poisoning. Fundamental and Appied Toxicology 1982, 4:106-115.
5. Ekstrom F., Akfur C., Tunemalm A.K., Lundberg S. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 2006, 45:74-81.
6. Kassa J., Kuca K., Bartosova L., Kunesova G. The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Current Organic Chemistry 2007, 11:267-283.
7. Kim T.H., Kuca K., Jun D., Jung Y.S. Design and synthesis of new bis-pyridinium oxime reactivators for acetyleholinesterase inhibited by organophosphorous nerve agents. Bioorganic & Medicinal Chemistry Letters 2005, 15:2914-2917.
8. Kuca K., Cabal J. Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin nerve agent. Toxicology Mechanisms and Methods 2005, 15:247-252.
9. Kuca K., Cabal J., Jun D., Kassa J., Bartosova L., Kunesova G., Dohnal V. Development of new acetylcholinesterase reactivators-antidotes used for treatment of nerve agent poisonings. Biomedical Papers 2005, 149:429-431.
10. Kuca K., Cabal J., Kassa J., Jun D., Hrabinova M. In vitro potency of H oximes (HI-6, HLo-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase. Journal of Toxicology and Environmental Health-Part a-Current Issues 2006, 69:1431-1440.
11. Kuca K, Jun D., Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini-Reviews in Medicinal Chemistry 2006, 6:269-277.
12. Kuca K., Kassa J. A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. Journal of Enzyme Inhibition and Medicinal Chemistry 2003, 18:529-535.
13. Lorke D.E., Hasan M.Y., Nurulain S.M., Sheen R., Kuca K., Petroianu G.A. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime. Journal of Applied Toxicology 2007, 27:482-490.
14. Marrs T.C. Organophosphate poisoning. Pharmacological Therapy 1993, 58:51-66.
15. Musilek K., Holas O., Hambalek J., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. Letters in Organic Chemistry 2006, 3:831-835.
16. Musilek K., Holas O., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorganic & Medicinal Chemistry Letters 2006, 16:5673-5676.
17. Musilek K., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Journal of Enzyme Inhibition and Medicinal Chemistry 2005, 20:409-415.
18. Musilek K., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorganic & Medicinal Chemistry Letters 2006, 16:622-627.
19. Musilek K., Lipka L., Racakova V., Kuca K., Jun D., Dohnal V., Dolezal M. New methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chemical Papers-Chemicke Zvesti 2006, 60:48-51.
20. Oh K.A., Yang Y., Jun D., Kuca K., Jung Y.S. Bis-pyridiumaldoxime reactivators connected with CH2O(CH2)(n)OCH2 linkers between pyridinium rings and their reactivity against VX. Bioorganic & Medicinal Chemistry Letters 2006, 16:4852-4855.
21. Park N.J., Jung Y.S., Musilek K., Jun D., Kuca K. Potency of several structurally different acetylcholinesterase Reactivators to reactivate house fly and bovine acetylcholinesterases inhibited by paraoxon and DFP. Bulletin of the Korean Chemical Society 2006, 27:1401-1404.
22. Patocka J., Jun D., Bajgar J., Kuca K. Prophylaxis against nerve agent intoxications. Defence Science Journal 2006, 56:775-784.
23. Petroianu G.A., Arafat K., Kuca K., Kassa J. Five oximes (K-27, K-33, K-48, Bl-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetyl cholinesterase inhibited by paraoxon. Journal of Applied Toxicology 2006, 26:64-71.
24. Petroianu G.A., Nurulain S.M., Nagelkerke N., Al-Sultan M.A.H., Kuca K., Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. Journal of Applied Toxicology 2006, 26:262-268.
25. Puu G., Artursson E., Bucht G. Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime. Biochemical Pharmacology 1986, 35:1505-1510.
26. Rakonczay Z. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain. Acta Biologica Hungarica 2003, 54:183-189.
27. Sakurada K., Matsubara K., Shimizu K., Shiono H., Seto Y., Tsuge K., Yoshino M., Sakai I., Mukoyama H., Takatori T. Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochemical Research 2003, 28:1401-1407.
28. Worek F., Widmann R., Knopff O., Szinicz L. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Archives of Toxicology 1998, 72:237-243.